Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM

被引:27
作者
Belmares, MP
Busch, R
Mellins, ED
McConnell, HM [1 ]
机构
[1] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
关键词
D O I
10.1021/bi020466p
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Major histocompatability class II proteins are transmembrane alphabeta-heterodimers that present peptides to T-cells. MHC II may bind exogenous peptides directly at the cell surface. Alternatively, peptides derived from processing of endosomal protein may bind to MHC II in endosomal compartments. There, HLA-DM catalyzes the formation of peptide/MHC complexes, which are then transported to the cell surface. Here we report evidence that the peptide Ii CLIP 81-104 binds to DR*0404 in two alternate registries, whose dissociation rates, while kinetically indistinguishable at pH 5.3 and 37degreesC, are kinetically resolved in the presence of HLA-DM. In one registry isomer, CLIP Met 91 is placed in the N-terminal P1 pocket of DR*0404, and peptide dissociation is readily catalyzed by HLA-DM. In a second proposed registry, likely with CLIP Leu 97 in the P1 pocket, the complex is substantially less sensitive to HL-ADM catalysis. Without HLA-DM, or at pH 7, the fraction of each isomer formed in solution is relatively insensitive to the duration of incubation with peptide. However, with HLA-DM, the fraction of the DM-insensitive isomer is dramatically influenced by peptide incubation time. The mechanism of isomer formation appears to be determined by the HLA-DM-modified relative association to the two registries, followed by HLA-DM-catalyzed dissociation of each isomer and rebinding, leading to a final isomer composition determined by these kinetic constants. Intramolecular isomer interconversion does not appear to be involved. The behavior of these complexes may provide a model for peptide editing by DM in endosomes.
引用
收藏
页码:838 / 847
页数:10
相关论文
共 50 条
[1]   Major histocompatibility complex class II-dependent unfolding, transport, and degradation of endogenous proteins [J].
Aichinger, G ;
Karlsson, L ;
Jackson, MR ;
Vestberg, M ;
Vaughan, JH ;
Teyton, L ;
Lechler, RI ;
Peterson, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :29127-29136
[2]  
Arunachalam B, 1998, J IMMUNOL, V160, P5797
[3]   Isomeric complexes of peptides with class II proteins of the major histocompatibility complex [J].
Beeson, C ;
Anderson, TG ;
Lee, C ;
McConnell, HM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (05) :977-980
[4]   Kinetics of registry selection of chimeric peptides binding to MHC II [J].
Belmares, MP ;
McConnell, HM .
BIOCHEMISTRY, 2001, 40 (34) :10284-10292
[5]  
BELMARES MP, 2002, IN PRESS J IMMUNOL
[6]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[7]   Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM [J].
Busch, R ;
Reich, Z ;
Zaller, DM ;
Sloan, V ;
Mellins, ED .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (42) :27557-27564
[8]   Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum [J].
Busch, R ;
Cloutier, I ;
Sekaly, RP ;
Hammerling, GJ .
EMBO JOURNAL, 1996, 15 (02) :418-428
[9]   HLA-DM recognizes the flexible conformation of major histocompatibility complex class II [J].
Chou, CL ;
Sadegh-Nasseri, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1697-1706
[10]   DETERMINANT CAPTURE AS A POSSIBLE MECHANISM OF PROTECTION AFFORDED BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES IN AUTOIMMUNE-DISEASE [J].
DENG, HK ;
APPLE, R ;
CLARESALZLER, M ;
TREMBLEAU, S ;
MATHIS, D ;
ADORINI, L ;
SERCARZ, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1675-1680